|
Yes |
Exclusion Criteria |
|
|
A. Exclusion of any
other cause of liver disease other than H C V (by liver
biopsy) |
|
|
B. Exclusion of
co-infection with HBV |
|
|
C. Exclusion of
hemochromatosis (by liver Biopsy) |
|
|
D. Exclusion of alpha
1-antitrypsin deficiency (by liver biopsy ) |
|
|
E. Exclusion of
Wilson's disease (by liver biopsy) |
|
|
F. Exclusion of
autoimmune disease (ANA) |
|
|
G. Exclusion of
alcoholic liver disease |
|
|
H. Exclusion of
decompensated liver disease |
|
|
I. Exclusion of
hypersensitivity to interferon or Ribavirin
|
|
|
J. Exclusion of any
other condition which in the judgment of investigator
disqualifies the patient from entering the protocol
|
|
|
K. Exclusion of
pregnancy or breast feeding |
|
|
L. Exclusion of
poorly controlled diabetes |
|
|
M. Exclusion of
clinically significant retinal abnormalities
|
|
|
N. Exclusion of
obesity -induced liver disease
|
|
|
O. Exclusion of drug-
related liver disease |
|
|
P. Exclusion of CNS
trauma which requires medication |
|
|
Q. Exclusion of
active seizures which requires medication
|
|
|
R. Exclusion of
ischemic cardiovascular disease within the last 6 months
|
|
|
S. Exclusion of
immunologically mediated disease (ulcerative colitis,
Crohn,s disease .ITP. SLE autoimmune hemolytic anemia,
scleroderma , severe psoriasis and rheumatoid arthritis)
|
|
|
T. Exclusion of
patients with organ transplants |
|
|
U. Exclusion of
substance abuse (alcohol >80gm/d) iv drugs and inhaled
drugs |
|
|
V. If past history of
substance abuse abstention for the post 12 months? |
|
|
W. Exclusion of
amantadine ,flumantadine, steroids, siercide, and/or
immunosuppressive drugs |
|
|
X. Exclusion of sever
pre- existing psychiatric conditions |
|
|
Y. Exclusion of any
history of manic element associated to prior psychiatric
history |